Diabetes Rates Rise Sharply in Israel, Especially Among Older Adults
Translated & summarized from Ynet by baba
Diabetes affects 7.5% of Israelis, with rates significantly higher among older adults and disparities evident across socioeconomic and ethnic groups. New data shows a 10.1% prevalence in the 20-79 age group, exceeding Europe but below the US. Experts link the rise to lifestyle and food environment changes, while acknowledging challenges in access to advanced treatments due to high costs.
The story in 6 lines · by baba
- 7.5% of Israelis, totaling over 708,000 people, lived with diabetes in 2024.
- Diabetes prevalence rises sharply with age, affecting over a third of those 65 and older.
- Israel's diabetes rate is higher than Europe's average but lower than the US.
- Significant disparities exist in diabetes rates and management among socioeconomic and ethnic groups.
- Lifestyle changes and processed food availability are linked to increased diabetes rates.
- New treatments offer hope, but high costs pose access challenges.
New data from the National Center for Disease Control reveals that 7.5% of Israelis aged two and older, totaling 708,553 people, were living with diabetes in 2024. The prevalence of the disease increases significantly with age, with 33.4% of those aged 65-84 and 35.3% of those 85 and older affected. The rate is slightly higher among men (7.9%) than women (7.2%).
Internationally, Israel's diabetes rate among those aged 20-79 stands at 10.1%, which is higher than the European average (8%) but lower than the United States (13.7%) and China (11.9%). Dr. Moran Blaichfeld-Magnazi, Director of the Nutrition Department at the Ministry of Health, attributed the rise in diabetes to changes in the food environment and lifestyle, citing increased availability and aggressive marketing of processed foods, coupled with faster-paced lives, less time for cooking, and increased stress.
The report also highlights significant disparities. Among individuals aged 55-64, the diabetes rate in lower socioeconomic strata was 25.7%, more than double that of their higher socioeconomic counterparts (11.3%). Similar gaps were observed in older age groups. The Arab population also shows higher rates, with 12.7% of those aged 45-54 affected, more than twice the rate in the Jewish population (6%). These disparities extend to disease management, with lower rates of balanced blood sugar levels among Arab and lower socioeconomic populations, increasing their risk of complications.
Ran Granot, who was diagnosed with Type 1 diabetes at age five and a half, shared his lifelong experience managing the condition, including the challenges of maintaining spontaneity and participating in activities like basketball. He now volunteers with the Type 1 Diabetes Association and serves as president of its summer camp for children, an experience he described as life-changing.
Experts emphasize that while diabetes cannot be cured, it can be managed. Prof. Roi Eldor, Director of the Endocrinology Institute at Tel Aviv Medical Center, noted advancements in treatments for both Type 1 and Type 2 diabetes, including new medications that can slow disease progression and protect organs. He stressed the importance of early diagnosis and aggressive treatment, combining medication with lifestyle changes. However, the high cost of new medications remains a significant barrier to access, though prices are expected to decrease over time.